The approval makes Algatech the first astaxanthin supplier to market the ingredient in Brazil, according to the company. The ingredient comes from the Haematococcus pluvialis microalgae, cultivated in a controlled closed system of glass photo-bioreactors energized by natural sunlight in Israel’s Arava desert.
Citing Euromonitor data, the company reported that vitamins and dietary supplements recorded a sales total of US$1.3bn in 2015 in Brazil, an 11% year-over-year increase.
“Brazil holds the leading supplement market in South America, and we strongly believe this approval will create further possibilities in the region,” said Gary Brenner, project development manager for Algatech. “Collaborating with our distributor Ayalla, Sao Paulo, we aim to increase our sales and promote our products in cooperation with the leading brand customers in the food, cosmetics and dietary supplements segments."
“Ayalla prides itself in marketing only the highest quality natural nutrients to our Brazilian customers,” said Sandra Ayala de Anselmo, president of marketing for Ayalla. “For two generations, our family has maintained a strong commitment to these standards. Many of our strategic customers already know AstaPure astaxanthin, and we are excited to now realize our investment with the help of Algatech.”
“Microalgae is expected to be one of the most important nutrition source of the 21th century. We are proud to be among just a few companies internationally that have cracked the code for commercial-scale production of natural microalgae, at the highest standards,” said Hagai Stadler, CEO of Algatech. “We are pleased to bring the Algatech product line to Brazil, and to be able to provide for the first time in Brazil all-natural astaxanthin AstaPure.”